Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ICPT

Intercept Pharmaceuticals (ICPT) Stock Price, News & Analysis

Intercept Pharmaceuticals logo

About Intercept Pharmaceuticals Stock (NASDAQ:ICPT)

Advanced Chart

Key Stats

Today's Range
$19.00
$19.00
50-Day Range
$18.20
$19.00
52-Week Range
$8.82
$21.86
Volume
N/A
Average Volume
1.36 million shs
Market Capitalization
$794.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ICPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intercept Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ICPT Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
See More Headlines

ICPT Stock Analysis - Frequently Asked Questions

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) released its quarterly earnings results on Wednesday, August, 2nd. The biopharmaceutical company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.56) by $0.42. Intercept Pharmaceuticals's revenue for the quarter was up 16.6% on a year-over-year basis.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Intercept Pharmaceuticals investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Sarepta Therapeutics (SRPT), Netflix (NFLX), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

Company Calendar

Last Earnings
8/02/2023
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ICPT
CIK
1270073
Employees
341
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.48)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$221.82 million
Net Margins
-19.39%
Pretax Margin
-18.09%
Return on Equity
-77.48%
Return on Assets
-11.99%

Debt

Debt-to-Equity Ratio
3.12
Current Ratio
4.22
Quick Ratio
2.52

Sales & Book Value

Annual Sales
$285.71 million
Price / Sales
2.78
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.72 per share
Price / Book
11.05

Miscellaneous

Outstanding Shares
41,830,000
Free Float
39,192,000
Market Cap
$794.77 million
Optionable
Optionable
Beta
0.88

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:ICPT) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners